Lupin Limited
Search results
6 days ago · Biocon Biologics is a global company that develops and commercializes biosimilars, insulins and other biologics. It aims to make healthcare affordable and accessible to millions of patients and their families across the world.
5 days ago · Biocon develops and manufactures affordable biosimilars, generic formulations and complex APIs for global markets. It also conducts research services and social initiatives for healthcare access and sustainability.
Biocon Biologics is a leading biopharmaceutical company that develops and manufactures affordable biosimilars for cancer, autoimmune and diabetes. Learn about its vision, values, journey, products and sustainability efforts.
Biocon is a biotechnology company that offers a range of products, including generics, biosimilars, branded formulations and novel biologics. It aims to meet unmet patient needs and provide affordable access to advanced therapies for chronic conditions such as diabetes, oncology and immunology.
Biocon Biologics is a global biosimilars organization with a strong research pipeline of molecules for diabetes, oncology, immunology and other diseases. Follow its LinkedIn page to get updates...
Over the years, Biocon Biologics has grown into a leading global biosimilars player, enabling affordable access to life-saving medicines and transforming patients’ lives across the world.
3 days ago · Biocon Biologics will submit a comprehensive Corrective and Preventive Action (CAPA) plan to the agency and is confident of addressing these observations expeditiously. The Company does not foresee the outcome of these inspections to impact the supply of its commercial products. Biocon Biologics remains committed to global standards of Quality & Compliance and to serving patients across the world.” – Company Spokesperson.
Biocon Biologics is a fully integrated biosimilars company that develops, manufactures, and commercializes high quality biosimilars worldwide. Learn about its history, portfolio, impact, and vision for a healthier and affordable future.
Biocon Biologics is a fully integrated biosimilars company with a unique portfolio of monoclonal antibodies and insulins. Learn about its history, products, partnerships, and vision for advancing biosimilars for a healthier and affordable future.
23 hours ago · "Biocon Biologics will submit a comprehensive Corrective and Preventive Action (CAPA) plan to the agency and is confident of addressing these observations expeditiously. The company does not foresee the outcome of these inspections to impact the supply of its commercial products. Biocon Biologics remains committed to global standards of quality & compliance and to serving patients across the world," the company spokesperson said.
